Literature DB >> 29536477

Follow-up after acute Pulmonary Embolism.

Frederikus A Klok, Stefano Barco.   

Abstract

In addition to among others major bleeding from anticoagulant therapy and recurrent venous thromboembolism (VTE), patients who survived acute pulmonary embolism (PE) face an increased risk of chronic functional limitations and decreased quality of life. In recent years, this latter complications have been better framed within the evolving definition of "post-PE syndrome" of which chronic thromboembolic pulmonary hypertension (CTEPH) represents the most extreme presentation. The post-PE syndrome in all its aspects is a frequent and clinically relevant long-term complication of PE but -except for CTEPH- has been largely understudied. There is great need to better define and understand the natural course of acute PE, to predict the development of the post-PE syndrome and to evaluate the potential benefits evolving treatments such as cardiopulmonary rehabilitation. Schattauer GmbH.

Entities:  

Mesh:

Year:  2018        PMID: 29536477     DOI: 10.5482/HAMO-17-06-0020

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


  7 in total

1.  Impact of dedicated outpatient pulmonary follow-up for hospitalized patients with acute pulmonary embolism.

Authors:  Joseph G Noto; Parth Rali
Journal:  Pulm Circ       Date:  2022-01-20       Impact factor: 2.886

2.  Immediate and late impact of reperfusion therapies in acute pulmonary embolism.

Authors:  Luca Valerio; Frederikus A Klok; Stefano Barco
Journal:  Eur Heart J Suppl       Date:  2019-11-21       Impact factor: 1.803

3.  Post partum female with sudden-onset breathlessness.

Authors:  Kunal Deokar; Ram Niwas; Gopal Chawla; Nishant Chauhan
Journal:  Breathe (Sheff)       Date:  2020-06

4.  Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trial.

Authors:  Stacey Haukeland-Parker; Øyvind Jervan; Hege Hølmo Johannessen; Jostein Gleditsch; Knut Stavem; Kjetil Steine; Martijn A Spruit; René Holst; Mazdak Tavoly; Frederikus A Klok; Waleed Ghanima
Journal:  Trials       Date:  2021-01-06       Impact factor: 2.279

5.  Construction of a Risk Prediction Model for Hospital-Acquired Pulmonary Embolism in Hospitalized Patients.

Authors:  Lengchen Hou; Longjun Hu; Wenxue Gao; Wenbo Sheng; Zedong Hao; Yiwei Chen; Jiyu Li
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism.

Authors:  Olga Dzikowska-Diduch; Katarzyna Kurnicka; Barbara Lichodziejewska; Olga Zdończyk; Dominika Dąbrowska; Marek Roik; Szymon Pacho; Maksymilian Bielecki; Piotr Pruszczyk
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

7.  Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries.

Authors:  Stefano Barco; Luca Valerio; Andrea Gallo; Giacomo Turatti; Seyed Hamidreza Mahmoudpour; Walter Ageno; Lana A Castellucci; Gabriela Cesarman-Maus; Henry Ddungu; Erich Vinicius De Paula; Mert Dumantepe; Samuel Z Goldhaber; Maria Cecilia Guillermo Esposito; Frederikus A Klok; Nils Kucher; Claire McLintock; Fionnuala Ní Áinle; Paolo Simioni; David Spirk; Alex C Spyropoulos; Tetsumei Urano; Zhen-Guo Zhai; Beverley J Hunt; Stavros V Konstantinides
Journal:  Res Pract Thromb Haemost       Date:  2021-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.